Sentara Infusion Services recalls Vancomycin (a) 1.25GM IN NS 250ML, (b) 1.5GM IN NS 300ML, (c) 1000MG IN NS 200ML (d) 2GM IN 400ML NS, (e) 900MG IN NS 1…
- Recall date
- December 27, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0322-2023
- FDA classification
- Class II
- Brand / firm
- Sentara Infusion Services
- Sold / distributed
- Dispensed to Patients Nationwide.
Why it was recalled
Lack of sterility assurance
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Vancomycin (a) 1.25GM IN NS 250ML, (b) 1.5GM IN NS 300ML, (c) 1000MG IN NS 200ML (d) 2GM IN 400ML NS, (e) 900MG IN NS 180ML, (f) 500 MG NS 100ML, (g) 750 MG NS 150ML, antibiotic, Rx only, use with home pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
Get recall alerts
Free email alert whenever Sentara Infusion Services has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sentara Infusion Services